IL87171A - ANDC of human tissue factor inhibitor - Google Patents

ANDC of human tissue factor inhibitor

Info

Publication number
IL87171A
IL87171A IL8717188A IL8717188A IL87171A IL 87171 A IL87171 A IL 87171A IL 8717188 A IL8717188 A IL 8717188A IL 8717188 A IL8717188 A IL 8717188A IL 87171 A IL87171 A IL 87171A
Authority
IL
Israel
Prior art keywords
tfi
cdna
sequence
factor
tissue factor
Prior art date
Application number
IL8717188A
Other languages
English (en)
Hebrew (he)
Other versions
IL87171A0 (en
Original Assignee
Monsanto Co
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22410671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL87171(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/123,753 external-priority patent/US4966852A/en
Application filed by Monsanto Co, Univ Washington filed Critical Monsanto Co
Publication of IL87171A0 publication Critical patent/IL87171A0/xx
Publication of IL87171A publication Critical patent/IL87171A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL8717188A 1987-11-23 1988-07-21 ANDC of human tissue factor inhibitor IL87171A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/123,753 US4966852A (en) 1987-07-23 1987-11-23 DNA clone of human tissue factor inhibitor

Publications (2)

Publication Number Publication Date
IL87171A0 IL87171A0 (en) 1988-12-30
IL87171A true IL87171A (en) 1995-08-31

Family

ID=22410671

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8717188A IL87171A (en) 1987-11-23 1988-07-21 ANDC of human tissue factor inhibitor

Country Status (15)

Country Link
EP (1) EP0318451B1 (ko)
JP (5) JP2836823B2 (ko)
KR (1) KR930000274B1 (ko)
AT (1) ATE111518T1 (ko)
AU (1) AU604139B2 (ko)
CA (1) CA1341223C (ko)
DE (1) DE3851511T2 (ko)
DK (1) DK173536B1 (ko)
ES (1) ES2063769T3 (ko)
FI (1) FI93365C (ko)
IE (1) IE65393B1 (ko)
IL (1) IL87171A (ko)
NO (2) NO310466B1 (ko)
NZ (1) NZ225535A (ko)
PT (1) PT88076B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
ES2086521T3 (es) * 1990-01-25 1996-07-01 Univ Washington Proteina hibrida laci-factor x.
JPH0733336B2 (ja) * 1990-08-27 1995-04-12 モンサント カンパニー Ｌａｃｉと硫酸化ポリサッカライドとの組み合わせ抗凝固剤
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US5455338A (en) 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
HUP0501111A2 (en) 2001-10-15 2007-12-28 Chiron Corp Treatment of severe pneumonia by administration of tissue factor pathway inhibitor
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
AU2003243394B2 (en) 2002-06-07 2008-06-12 Takeda Pharmaceutical Company Limited Prevention and reduction of blood loss
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
DK1981519T3 (en) 2005-12-29 2018-02-19 Dyax Corp protease inhibition
JP5739816B2 (ja) 2008-12-19 2015-06-24 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉインヒビターおよび使用法
US8637454B2 (en) 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
LT3459564T (lt) 2010-01-06 2022-03-10 Takeda Pharmaceutical Company Limited Plazmos kalikreiną surišantys baltymai
NZ603028A (en) 2010-03-19 2014-11-28 Baxter Healthcare Sa Tfpi inhibitors and methods of use
KR102320178B1 (ko) 2011-01-06 2021-11-02 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
US8623666B2 (en) * 2011-06-15 2014-01-07 Hoffmann-La Roche Inc. Method for detecting erythropoietin (EPO) receptor using anti-human EPO receptor antibodies
KR102263685B1 (ko) 2012-03-21 2021-06-11 다케다 야쿠힌 고교 가부시키가이샤 Tfpi 저해제 및 사용 방법
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor

Also Published As

Publication number Publication date
CA1341223C (en) 2001-05-01
NZ225535A (en) 1990-11-27
IE65393B1 (en) 1995-10-18
AU1928788A (en) 1989-05-25
FI93365B (fi) 1994-12-15
EP0318451A3 (en) 1990-03-28
JP4025035B2 (ja) 2007-12-19
DK173536B1 (da) 2001-02-05
ES2063769T3 (es) 1995-01-16
JP3565714B2 (ja) 2004-09-15
JPH1175875A (ja) 1999-03-23
KR930000274B1 (ko) 1993-01-14
NO310466B1 (no) 2001-07-09
AU604139B2 (en) 1990-12-06
JP2005306875A (ja) 2005-11-04
DK413488D0 (da) 1988-07-22
DE3851511D1 (de) 1994-10-20
NO20013608D0 (no) 2001-07-20
EP0318451A2 (en) 1989-05-31
JP2836823B2 (ja) 1998-12-14
NO20013608L (no) 1989-05-24
DK413488A (da) 1989-05-24
FI883487A0 (fi) 1988-07-22
JP2004201696A (ja) 2004-07-22
JP2002097200A (ja) 2002-04-02
KR890007750A (ko) 1989-07-05
FI883487A (fi) 1989-05-24
EP0318451B1 (en) 1994-09-14
PT88076B (pt) 1993-01-29
PT88076A (pt) 1988-08-01
IL87171A0 (en) 1988-12-30
FI93365C (fi) 1995-03-27
ATE111518T1 (de) 1994-09-15
NO883270D0 (no) 1988-07-22
NO883270L (no) 1989-05-24
IE882243L (en) 1989-05-23
DE3851511T2 (de) 1995-03-30
JPH01165383A (ja) 1989-06-29

Similar Documents

Publication Publication Date Title
US4966852A (en) DNA clone of human tissue factor inhibitor
EP0318451B1 (en) DNA clone of human tissue factor inhibitor
US7060805B2 (en) Methods for isolating tissue factor inhibitor
Wun et al. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.
Sommer et al. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily
Freije et al. Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva
Sallenave et al. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions
AU711113B2 (en) Novel serpin derived from human hypothalamus
US6025143A (en) Antibodies directed against peptides derived from the SMR1 polypeptide
Silverman et al. SCCA1 and SCCA2 are proteinase inhibitors that map to the serpin cluster at 18q21. 3
Stallings-Mann et al. Purification, characterization, and cDNA cloning of a Kunitz-type proteinase inhibitor secreted by the porcine uterus.
Lai et al. Purification and characterization of a trypsin inhibitor from mouse seminal vesicle secretion
DK175431B1 (da) Antistoffer som binder fragmenter af vævsfaktorinhibitor (TFI), sammensætninger omfattende disse antistoffer, og fremgangsmåde til anvendelse af en immunoaffinitetsmatrix omfattende et sådant antistof til at oprense et polypeptid fra et biologisk fluidum
DK174754B1 (da) Humane vævsfaktorinhibitor (TFI), antistof med bindingsspecificitet herfor, fremgangsmåde til anvendelse af en TFI-peptid-kolonne til at oprense et antistof og fremgangsmåder til detektion af TFI eller et polypeptid omfattende....
Fletcher et al. Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA
US5637479A (en) Method of modulating DNA binding activity of recombinant α-1 antichymotrypsin and other serine protease inhibitors
Oliver Purification and partial characterization of canine angiotensinogen.
OHLSSON Chemistry and Biology of Secretory Leukoprotease Inhibitor
JPH07242700A (ja) 新規ポリペプチド

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired